SCHEMBL6170879

SCHEMBL6170879

Cn1c(Cc2ccccc2)nc2ccc(C(=O)NCc3ccccn3)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.56
PDE2A O00408 1/20 0.52
KDM4E B2RXH2 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
POLB P06746 2/20 0.52
ALDH1A1 P00352 2/20 0.52
MAPT P10636 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
THRB P10828 1/20 0.52
PKM P14618 1/20 0.52
ALOX15 P16050 1/20 0.52
NR4A1 P22736 1/20 0.52
APEX1 P27695 1/20 0.52
CASP1 P29466 1/20 0.52
PTPN7 P35236 1/20 0.52
RECQL P46063 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168527 0.87 NAMPT (0.54) NAMPTPDE2AKDM4EMEN1KMT2A
SCHEMBL6168396 0.81 AGTR1 (0.54) NAMPTPDE2AKDM4EPOLBALDH1A1
SCHEMBL6168528 0.80 KDM4E (0.59) NAMPTPDE2AKDM4EMEN1KMT2A
SCHEMBL6170298 0.80 PPARG (0.58) NAMPTPDE2AKDM4EMEN1KMT2A
SCHEMBL6172717 0.79 PPARG (0.53) PPARGHDAC1HDAC6
Hydrochloric Acid SCHEMBL6170063 0.78 PPARG (0.54) PPARG
SCHEMBL6169466 0.78 KDM4E (0.54) NAMPTPDE2AKDM4EMEN1KMT2A
SCHEMBL6173780 0.78 LMNA (0.56) NAMPTPDE2AKDM4EPOLBALDH1A1
SCHEMBL6167923 0.77 NAMPT (0.53) NAMPTPDE2AKDM4EMEN1KMT2A
SCHEMBL6171257 0.76 MAPT (0.58) NAMPTPDE2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6211177-B1 SIDE EFFECT REDUCTION CELL PATHWAYS, INC. 2001-04-03 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed